A-25-17 In re: Accutane Litigation (079958)
Order Admitting Richard Hansen - Schedule A
New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters
A-4952-16T1 - IN RE: ACCUTANE LITIGATION (MCL-271, ATLANTIC COUNTY AND STATEWIDE)
ORDER TO DELETE submitted by Case Management Staff October 30, 2017 | Trellis
Untitled
New Jersey Supreme Court Sets Higher Standards For Expert Opinions | Respond Law
In re Accutane Litigation Archives - Government & Law Blog
NJ Court's Exclusion of Experts in Accutane Litigation
Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate Division – Peabody & Arnold
Expert Evidence | New Jersey Civil Justice Institute
2020 Thomson Reuters. No claim to original U.S. Government Works. 1 235 N.J. 229 Supreme Court of New Jersey. IN RE: ACCUTANE
Untitled
Order Granting Summary Judgment on Lack of Proximate Cause Schedule A and Schedule B
On the WLF Legal Pulse
Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal | New Jersey Law Journal
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP
Everything You Need to Know About Microdosing Accutane for Acne
Roche faces more than 2K Accutane liability cases as appeals panels reverse rulings | Fierce Pharma
Accutane Lawsuit Status – Injuries & Jury Verdicts
